乳腺癌中ferroptosis研究的现状和未来方向:书法测量分析
Jia-Yuan Luo1, Yu-Long Deng2, Shang-Yi Lu3
1Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Interactive journal of medical research
|February 26, 2025
概括
铁灭菌研究正在迅速推进乳腺癌治疗. 未来的战略重点是瘤微环境中的免疫疗法和纳米疗法,以改善临床结果.
科学领域:
- 生物医学科学 生物医学科学
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
背景情况:
- 铁灭,一种新的细胞死亡机制,为了解乳腺癌的发病机制提供了显著的潜力.
- 这项研究探讨了铁化作为促进乳腺癌治疗策略的关键领域.
研究的目的:
- 对乳腺癌中的铁灭症研究进行全面的文献分析.
- 确定当前的趋势,关键贡献者,以及未来的研究方向在这个领域.
主要方法:
- 来自Web of Science核心集合的387篇论文的图书统计分析.
- 使用R包Bibliometrix,VOSviewer和CiteSpace进行数据分析.
- 审查的作者,机构,期刊,国家,出版量,引用和关键词.
主要成果:
- 出版物产出每年都在急剧增加,中国和美国在研究方面处于领先地位.
- 癌症和Efferth T的边界是显著的贡献者;孙中山大学领导机构.
- 关键的研究领域包括ferroptosis诱导,蛋白调节和与其他细胞死亡类型的比较.
- 谷氨过氧化酶4研究已经成熟;乳腺癌亚型,瘤微环境,免疫疗法和纳米疗法是新兴的主题.
结论:
- 目前的研究重点是乳腺癌中的铁亡机制.
- 未来的研究将强调治疗策略,特别是瘤微环境中的免疫疗法和纳米疗法.
- 加快纳米疗法和免疫疗法的临床转化对于创新的乳腺癌治疗开发至关重要.
相关概念视频
02:55The Nucleolus
8.6K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:16Necrosis
3.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.9K